Osteoporosis Drug Treatment Update
Lindomar Guimarães Oliveira1, Mara Lúcia Rassi Guimarães Carneiro1, Márcio Passini Gonçalves de Souza2
1Departamento de Ortopedia e Traumatologia, Universidade Federal de Goiás, Goiânia, GO, Brasil.
Revista Brasileira De Ortopedia
|November 4, 2021
Summary
As osteoporosis prevalence rises with Brazil
Area of Science:
- Geriatric Medicine and Orthopedics
- Bone Metabolism and Disease
Background:
- Aging Brazilian population experiencing increased chronic degenerative diseases.
- Osteoporosis prevalence is rising, necessitating proactive management beyond fracture treatment.
Purpose of the Study:
- To outline essential diagnostic and therapeutic strategies for osteoporosis.
- To guide orthopedists and traumatologists in comprehensive osteoporosis care.
Main Methods:
- Utilizing the Fracture Risk Assessment Tool (FRAX) for risk factor evaluation.
- Recommending diagnostic tests: densitometry, radiography, blood/urine tests, and bone biopsy.
- Detailing supplement (calcium, magnesium, vitamins D & K) and medication (antiresorptives, trainers) guidelines, including therapeutic windows and adverse events.
Main Results:
- Established protocols for osteoporosis risk assessment and diagnosis.
- Defined therapeutic approaches involving nutritional supplements and pharmacological agents.
- Highlighted the importance of considering side effects and optimal drug usage.
Conclusions:
- Comprehensive management of osteoporosis requires evaluating risk factors, utilizing diagnostic tests, and prescribing appropriate supplements and medications.
- Orthopedic specialists must integrate medical management into their practice to address the growing burden of osteoporosis.
Related Concept Videos
01:29Bone Disorders
4.2K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
4.2K
01:31Osteoclasts in Bone Remodeling
3.4K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
3.4K
01:28Drug Therapy
118
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
118
01:26Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
282
Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
282
01:21Drug Dosing: Obese Patients
16
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
16
01:40Bone Remodeling
38.8K
Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
38.8K